What distinguishes TTI's TDS® platform technology is its demonstrated ability
to produce patentable new products when combined with established drugs.
The application of a delivery system like TDS® to the development of a a drug
product from a newly discovered chemical entity should logically accelerate
its timeline since the longest and most expensive piece of drug development has
to do with accounting for the effects of the drug on the digestive system. TDS®
plus a new drug could go from in vitro studies to pre-clinical trials as soon as
a safe and effective dose range can be proposed. This versatility allows TTI to
explore incorporating its technology in a wide range of pharmaceutical,
cosmeceutical and nutritional uses.

TTI is constantly evaluating potential new drug development candidates.
In performing this evaluation, TTI considers a variety of criteria including
compatibility with TDS®, the nature of the medical condition to be treated,
the market potential of the resulting drug and the relevant intellectual
property landscape.

In conclusion, TTI has a number of potentially significant product opportunities
already in development. TTI believes our products will incrementally improve
medicine, and consequently patients’ lives and our shareholders prospects for
decades to come!